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FATAL SUBCUTANEOUS EMPHYSEMA 
SECONDARY TO PULMONARY NOCARDIOSIS 
IN AN IMMUNOCOMPROMISED PATIENT
- A Case Report -
MUhaMMad iMran* and haMeed Ullah**
We report a case of necrotizing pulmonary nocardiosis complicated by subcutaneous 
emphysema in a 54 years old male patient receiving immunosuppressive therapy following 
renal transplant. The subcutaneous emphysema progressed rapidly and despite intervention, the 
response was poor resulting in fatal cardiorespiratory failure.
Case Report
A 54-year-old male patient was admitted through emergency with recent onset of productive 
cough with hemoptysis and fever which was gradually increasing since the previous 3 days. He 
also had a small chest wound just under his right nipple. He had undergone renal transplantation 
2 years ago due to chronic renal failure secondary to focal segmental glomerulonephritis and was 
receiving corticosteroids since then. He also had hypertension and acid-peptic disease for which 
he was taking medications.
Laboratory investigations revealed leucocytosis with neutrophil predominance, high serum 
creatinine and blood urea nitrogen and low serum bicarbonate levels. Chest X-ray (CXR) 
revealed right sided homogenus opacity in mid zone extending to invade the skin just below the 
nipple. Diagnosis of graft rejection and pneumonia secondary to immunosuppression was made 
and empiric broad spectrum antimicrobial and antifungal were started. For immunosuppression, 
cyclosporin and mycophenolate mofetil were initiated and prednisolone continued. Sputum 
and broncho alveolar lavage (BAL) was sent for culture and acid-fast bacilli (AFB) smear. 
Microbiology report showed growth of methicillin-resistant staphylococcus aureus (MRSA) and 
escherichia coli (E. coli), following which antibiotics were changed to those sensitive to the 
organisms.
Until this time patient was able to maintain acceptable arterial blood gases on oxygen 
therapy, but on the third day of admission he started to become hypoxic despite supplemental 
oxygen and developed severe respiratory acidosis. He also developed tachypnea and became 
drowsy which gradually worsened and therefore was electively intubated and shifted to intensive 
care unit for mechanical ventilation and further management.
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despite all attempts at cardiopulmonary resuscitation, 
he could not be revived.
Discussion
The genus Nocardia is a member of the order 
Actinomycetales, found in soil, plants and decomposing 
organic material1. Nocardia is divided into several 
species of which Nocardia asteroides accounts for 
the vast majority of clinical nocardial infection in 
humans2.
Immunosuppression is a well established 
risk factor for nocardiosis as was our patient. A 
compilation of more than a thousand randomly 
selected cases from the literature showed that more 
than 60% of all reported cases of nocardiosis are 
associated with preexisting immunosuppression, 
with the most common being corticosteroid treatment 
and immunosuppressive therapy3. The incidence of 
nocardiosis in renal transplant recipients varies from 
2 to 20%4,5. Beaman comprehensively reviewed the 
published literature and found 140 (21.8%) cases of 
nocardiosis in organ transplant recipients, of which 81 
(58%) were in renal transplant recipients3.
Pulmonary disease is the predominant clinical 
presentation of nocardiosis, with almost 90% of these 
caused by members of the N. asteroides complex6. 
The incidence of pulmonary nocardiosis is increasing 
due to a higher degree of clinical suspicion and the 
increasing number of immunosuppressive factors. 
Characteristically radiological manifestations may 
include consolidations, irregular nodules, often 
cavitatory, reticulonodular or diffuse infiltrates, and 
pleural effusions7.
Clinicians should be aware that pulmonary 
nocardiosis is difficult to diagnose on the basis of 
clinical and radiological findings. A high level of 
clinical suspicion is required in patients with risk 
factors. Growth of Nocardia may take from 48 hours 
to several weeks, but typical colonies are usually seen 
from 3 to 5 days. In pulmonary nocardiosis, sputum 
culture is the most frequently used diagnostic test. 
This patient showed growth of nocardia on second 
bronchioalveolar lavage approximately fourteen days 
after his sickness. Successful therapy requires the use 
of antimicrobial drugs in combination with appropriate 
His fever and leucocytosis gradually settled but 
chest x-ray showed increasing opacities. Ventilatory 
requirements gradually decreased and weaning was 
being considered. His chest wound was debrided 
and daily dressings were done which was also 
improving. During his intensive care unit stay he 
remained hemodynamically stable except for two 
episodes of atrial fibrillation which responded to 
intravenous amiodarone. Intermittent hemodylsis 
continued throughout his ICU stay. He also remained 
neurologically intact.
On 7th day of ICU admission, the patient 
developed subcutaneous emphysema just under right 
nipple on the margins of the wound. A chest computed 
tomography (CT) scan was done which revealed 
cavitatory lesions with evidence of pleurocutaneous 
fistula. Cardiothoracic surgery was consulted. As there 
was no pneumothorax, subcutaneous emphysema 
was localized and the ventilatory requirements were 
minimal, any intervention was deferred. Antibiotic 
spectrum was broadened to include coverage of gas 
forming organism like nocardia.
Next day white blood cell count increased and 
BAL was performed which showed growth of nocardia 
for which septran was added. His subcutaneous 
emphysema gradually increased along with worsening 
chest lesions despite appropriate antibiotics over the 
following 2 days. Even at this time his ventilatory 
requirements continued to decrease with consideration 
of plan for gradual progress to tracheal extubation.
Next morning, his emphysema increased rapidly 
progressing up to the face and down to the groins. 
Simultaneously his ventilatory requirement increased 
and he started to become hemodynamically unstable 
requiring inotropic support. Chest x-ray at this point 
showed pneumomediastinum, pneumopericardium and 
bilateral pneumothorax. Cardiothoracic surgery opinion 
was sought and a decision of bilateral chest tubes, 
fasciotomies was made. Possibility of isolation of lung 
was also discussed. Considering the difficult airway 
due to severe facial subcutaneous emphysema, it was 
decided to take the patient to the operating room. While 
arrangements were being made for the transfer of the 
patient, multiple chest tube insertions and fasciotomies 
were performed in the intensive care unit. At this point 
patient suddenly developed asystolic cardiac arrest and 
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pneumomediastinum14. It also causes difficulties in 
the reading of chest radiographs, echocardiography, 
ultrasound, and electrocardiograms15. Prompt diagnosis 
and treatment is necessary before rapid deterioration 
may suddenly compromise cardiorespiratory system16.
Treatment should not be delayed awaiting further 
cardiovascular and respiratory compromise. As soon 
as pneumothorax is suspected, the pleural space 
should be decompressed. Surprisingly, in our patient 
mechanical ventilatory parameters were reasonable till 
the last day when rapid deterioration in subcutaneous 
emphysema caused a compromise in the delivery of 
adequate minute ventilation finally resulting in fatal 
cardiopulmonary failure.
Although the subcutaneous emphysema in 
nocardiosis is rare, it is important for the clinicians to 
be aware of this and should intervene early as it may 
rapidly progress resulting in acute cardio-respiratory 
failure.
surgical drainage or debridement. The clinical outcome 
of therapy for nocardiosis is dependent on the site and 
extent of disease and underlying host factors. Mortality 
rates between 20-40% are mentioned in different 
series and may reach 80-100% in disseminated central 
nervous system disease8.
The association of chest wall subcutaneous 
emphysema is les common with pulmonary infections9 
and not reported with nocardiosis. Extension of air 
from respiratory tracts may produce pneumothorax, 
pneumomediastinum, pneumopericardium, or 
retroperitoneal collections of air. Subcutaneous 
emphysema can also extend into the soft tissues of the 
head and neck upwards and up to legs downwards10. 
Although in most instances subcutaneous emphysema 
is of little clinical importance, it may be fatal if it leads to 
upper airway obstruction11, acute respiratory failure due 
to chest wall compression12, intracranial hypertension13, 
and circulatory collapse in association with tension 
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